Effects of PIN on Osteoblast Differentiation and Matrix Mineralization Through Runt-Related Transcription Factor

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2020 Dec 19

PMID 33339165

Citations 10

Authors

Kyung-Ran Park

Soohyun Kim

Myounglae Cho

Sang Wook Kang

Hyung-Mun Yun

Affiliations

Soon will be listed here.

Abstract

Sieb. et Zucc. has been used as traditional medicine in inflammatory diseases, and isolated compounds have shown pharmacological activities. Pinoresinol glucoside (PIN) belonging to lignins was isolated from the stem bark of This study aimed to investigate the biological function and mechanisms of PIN on cell migration, osteoblast differentiation, and matrix mineralization. Herein, we investigated the effects of PIN in MC3T3-E1 pre-osteoblasts, which are widely used for studying osteoblast behavior in in vitro cell systems. At concentrations ranging from 0.1 to 100 μM, PIN had no cell toxicity in pre-osteoblasts. Pre-osteoblasts induced osteoblast differentiation, and the treatment of PIN (10 and 30 μM) promoted the cell migration rate in a dose-dependent manner. At concentrations of 10 and 30 μM, PIN elevated early osteoblast differentiation in a dose-dependent manner, as indicated by increases in alkaline phosphatase (ALP) staining and activity. Subsequently, PIN also increased the formation of mineralized nodules in a dose-dependent manner, as indicated by alizarin red S (ARS) staining, demonstrating positive effects of PIN on late osteoblast differentiation. In addition, PIN induced the mRNA level of BMP2, ALP, and osteocalcin (OCN). PIN also upregulated the protein level of BMP2 and increased canonical BMP2 signaling molecules, the phosphorylation of Smad1/5/8, and the protein level of Runt-related transcription factor 2 (RUNX2). Furthermore, PIN activated non-canonical BMP2 signaling molecules, activated MAP kinases, and increased β-catenin signaling. The findings of this study indicate that PIN has biological roles in osteoblast differentiation and matrix mineralization, and suggest that PIN might have anabolic effects in bone diseases such as osteoporosis and periodontitis.

Citing Articles

Pro-differentiative, Pro-adhesive and Pro-migratory Activities of Isorhamnetin in MC3T3-E1 Osteoblasts via Activation of ERK-dependent BMP2-Smad Signaling.

Li J, Sun L, Wang F, Yin S, Li S, Zhang J Cell Biochem Biophys. 2024; 82(4):3607-3617.

PMID: 39136840 DOI: 10.1007/s12013-024-01450-2.

Intraspecific Differentiation of (Styracaceae) as Revealed by Comparative Chloroplast and Evolutionary Analyses.

Zheng H, Dai W, Xu M, Lin Y, Zhu X, Long H Genes (Basel). 2024; 15(7).

PMID: 39062719 PMC: 11275416. DOI: 10.3390/genes15070940.

Effects of Scoparone on differentiation, adhesion, migration, autophagy and mineralization through the osteogenic signalling pathways.

Park K, Kim B, Lee J, Moon H, Kwon I, Yun H J Cell Mol Med. 2022; 26(16):4520-4529.

PMID: 35796406 PMC: 9357629. DOI: 10.1111/jcmm.17476.

MiR-29a-3p Inhibits Proliferation and Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells via Targeting FOXO3 and Repressing Wnt/-Catenin Signaling in Steroid-Associated Osteonecrosis.

Wang C, Zhu M, Yang D, Hu X, Wen X, Liu A Int J Stem Cells. 2022; 15(3):324-333.

PMID: 35769053 PMC: 9396013. DOI: 10.15283/ijsc21147.

Biochemometry-Based Discovery of Phenylpropanoids from Fruits as Inhibitors of In Vitro Osteoclast Formation.

Tahir A, Kampleitner C, Wirglauer T, Grienke U, Hoffmann O, Rollinger J Molecules. 2022; 27(11).

PMID: 35684547 PMC: 9182001. DOI: 10.3390/molecules27113611.

References

Yoshikawa K, Hirai H, Tanaka M, Arihara S . Antisweet natural products. XV. Structures of Jegosaponins A-D from Styrax japonica Sieb. et Zucc. Chem Pharm Bull (Tokyo). 2000; 48(7):1093-6. DOI: 10.1248/cpb.48.1093. View

Guiglia R, Di Fede O, Russo L, Sprini D, Rini G, Campisi G . Osteoporosis, jawbones and periodontal disease. Med Oral Patol Oral Cir Bucal. 2012; 18(1):e93-9. PMC: 3548653. DOI: 10.4317/medoral.18298. View

Min B, Oh S, Ahn K, Kim J, Lee J, Kim D . Anti-complement activity of norlignans and terpenes from the stem bark of Styrax japonica. Planta Med. 2005; 70(12):1210-5. DOI: 10.1055/s-2004-835853. View

Kern B, Shen J, Starbuck M, Karsenty G . Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem. 2000; 276(10):7101-7. DOI: 10.1074/jbc.M006215200. View

Park K, Kim E, Hong J, Yun H . Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss. Theranostics. 2018; 8(11):3087-3098. PMC: 5996355. DOI: 10.7150/thno.24426. View

Chen Y, Whetstone H, Youn A, Nadesan P, Chow E, Lin A . Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem. 2006; 282(1):526-33. DOI: 10.1074/jbc.M602700200. View

Bikkavilli R, Malbon C . Mitogen-activated protein kinases and Wnt/beta-catenin signaling: Molecular conversations among signaling pathways. Commun Integr Biol. 2009; 2(1):46-9. PMC: 2649302. DOI: 10.4161/cib.2.1.7503. View

Owen R, Bahmaee H, Claeyssens F, Reilly G . Comparison of the Anabolic Effects of Reported Osteogenic Compounds on Human Mesenchymal Progenitor-derived Osteoblasts. Bioengineering (Basel). 2020; 7(1). PMC: 7148480. DOI: 10.3390/bioengineering7010012. View

Artigas N, Urena C, Rodriguez-Carballo E, Rosa J, Ventura F . Mitogen-activated protein kinase (MAPK)-regulated interactions between Osterix and Runx2 are critical for the transcriptional osteogenic program. J Biol Chem. 2014; 289(39):27105-27117. PMC: 4175347. DOI: 10.1074/jbc.M114.576793. View

10.

Marie P . Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies. Cell Mol Life Sci. 2014; 72(7):1347-61. PMC: 11113967. DOI: 10.1007/s00018-014-1801-2. View

11.

Russow G, Jahn D, Appelt J, Mardian S, Tsitsilonis S, Keller J . Anabolic Therapies in Osteoporosis and Bone Regeneration. Int J Mol Sci. 2018; 20(1). PMC: 6337474. DOI: 10.3390/ijms20010083. View

12.

Kim A, Ko H, Chowdhury M, Chang Y, Woo E . Chemical constituents on the aerial parts of Artemisia selengensis and their IL-6 inhibitory activity. Arch Pharm Res. 2015; 38(6):1059-65. DOI: 10.1007/s12272-014-0543-x. View

13.

Kim M, Song Y, Hwang J . Kirenol stimulates osteoblast differentiation through activation of the BMP and Wnt/β-catenin signaling pathways in MC3T3-E1 cells. Fitoterapia. 2014; 98:59-65. DOI: 10.1016/j.fitote.2014.07.013. View

14.

Lee H, Jung E, Bae S, Kwon K, Kim J, Suh H . Stimulation of osteoblastic differentiation and mineralization in MC3T3-E1 cells by yeast hydrolysate. Phytother Res. 2010; 25(5):716-23. DOI: 10.1002/ptr.3328. View

15.

Fakhry M, Hamade E, Badran B, Buchet R, Magne D . Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World J Stem Cells. 2013; 5(4):136-48. PMC: 3812518. DOI: 10.4252/wjsc.v5.i4.136. View

16.

Park K, Lee H, Cho M, Yun H . A Phytochemical Constituent, (E)-Methyl-Cinnamate Isolated from Hayata Suppresses Cell Survival, Migration, and Differentiation in Pre-Osteoblasts. Int J Mol Sci. 2020; 21(10). PMC: 7279157. DOI: 10.3390/ijms21103700. View

17.

Zheng X, Dai J, Zhang H, Ge Z . MicroRNA-221 promotes cell proliferation, migration, and differentiation by regulation of ZFPM2 in osteoblasts. Braz J Med Biol Res. 2018; 51(12):e7574. PMC: 6207289. DOI: 10.1590/1414-431X20187574. View

18.

Ducy P, Zhang R, Geoffroy V, Ridall A, Karsenty G . Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997; 89(5):747-54. DOI: 10.1016/s0092-8674(00)80257-3. View

19.

Moon H, Kim M, Woo E, Chung J . Triterpenoid from Styrax japonica SIEB. et ZUCC, and its effects on the expression of matrix metalloproteinases-1 and type 1 procollagen caused by ultraviolet irradiated cultured primary human skin fibroblasts. Biol Pharm Bull. 2005; 28(10):2003-6. DOI: 10.1248/bpb.28.2003. View

20.

Marie P, Kassem M . Osteoblasts in osteoporosis: past, emerging, and future anabolic targets. Eur J Endocrinol. 2011; 165(1):1-10. DOI: 10.1530/EJE-11-0132. View